This inventor holds 3 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Kallyope, Inc., Merck Sharp + Dohme Corp., Pfizer Corporation. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- New York, NY (US) (2023)
- Tenafly, NJ (US) (2024)
Company Filing History:
2 out of 7 
1 out of 2,405 
1 out of 4,488 
Years Active: 2023-2026
Title: Brett Lauring: Innovator in Cardiovascular Treatment
Introduction
Brett Lauring is a notable inventor based in Tenafly, NJ (US). He has made significant contributions to the field of cardiovascular health through his innovative research and patenting efforts. His work focuses on methods to treat and reduce the risk of cardiovascular events using SGLT-2 inhibitors.
Latest Patents
Brett Lauring holds a patent for "Methods of treating or reducing the risk of cardiovascular events and related diseases using SGLT-2 inhibitors." This invention pertains to the use of specific SGLT-2 inhibitors, such as ertugliflozin, for treating and preventing heart failure, myocardial infarction, and other cardiovascular diseases in various animal models.
Career Highlights
Throughout his career, Lauring has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corp. and Pfizer Corporation. His experience in these organizations has allowed him to contribute to significant advancements in medical treatments.
Collaborations
Brett Lauring has collaborated with esteemed colleagues such as Samuel S. Engel and Steven G. Terra. These partnerships have further enhanced his research and development efforts in the field of cardiovascular health.
Conclusion
Brett Lauring's innovative work in the treatment of cardiovascular diseases showcases his dedication to improving health outcomes. His patent and collaborations reflect his commitment to advancing medical science and technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile